<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
12.02.2020 14:00:00

Gilead Sciences Looks Ready to Outpace AbbVie

Gilead Sciences (NASDAQ: GILD) and AbbVie (NYSE: ABBV) are two of the world's largest pharmaceutical stocks by market capitalization. AbbVie is the bigger of the two, at $139 billion to Gilead's $86 billion, and its stock value has grown significantly over the past year. When considering the long-term prospects, is either company a better fit for your portfolio? Here are the key takeaways on Gilead Sciences and AbbVie.Image Source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"